WCES 2025 in Singapore

BioCer was represented with great enthusiasm at the World Congress of Endoscopic Surgery (WCES) 2025 in Singapore, and the team was able to gather numerous positive impressions. The stand was very busy on all days of the fair – our colleagues had their hands full answering the numerous questions about our products.

Great interest and an international audience

The presentation of our solutions for endoscopic haemostasis attracted particular attention. With our Endoscopic Applicator and the haemostatic powder HaemoCer PLUS, we were able to show many trade visitors how procedures can be made safe and efficient. The positive feedback and intensive discussions confirm once again that high-quality medical technology is in demand worldwide.

We would like to thank all visitors, partners and organisers for the exciting exchange and are already looking forward to the next reunion.

BioCer news!

Whether trade fair reports, new products or company news – we will keep you up to date here.

Stay curious and follow our journey into modern medical technology.

Follow us on Social Media

BioCer is proud to be represented for the first time at the World Congress of Endoscopic Surgery (WCES)> in 2025 (Stand B10). This prestigious event, considered the world’s leading congress in the field of minimally invasive surgery, will take place from 4 to 8 November at the Suntec Convention & Exhibition Centre in Singapore, bringing together experts, surgeons and medical technology companies from around the world.

Solutions for minimally invasive surgery

Our exhibition stand offers an ideal platform to showcase BioCer’s innovative solutions. The focus is on our product range for minimally invasive procedures, including haemostatic agents and suture protection solutions, which are characterised by the highest quality, safety and user-friendliness. These products enable more efficient and safer operations – a decisive advance for modern surgery.

The WCES also offers us the opportunity to actively exchange ideas with leading specialists and decision-makers. With exciting lectures, workshops and live demonstrations, the congress is a valuable source of information on current trends and technological innovations. BioCer intends to use this knowledge to further develop its own products and make an important contribution to the future of minimally invasive surgery.

Participation in WCES 2025 marks an important step in the internationalisation of BioCer. In addition to product presentation, establishing new partnerships is a central component of our trade fair presence.

We cordially invite all congress visitors to visit our stand, see the quality of our products for themselves and discuss the future of minimally invasive surgery with us.

Event details:

Location: Suntec Convention & Exhibition Centre, Singapore

Date: 4–8 November 2025

Topics: Minimally invasive surgery, haemostatics, innovations in medical technology

The full programme and further information can be found on the official website: wces2025.com.